{
    "title": "Roche sales decline more than expected as COVID products slide",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11326575/Roche-sales-decline-expected-COVID-products-slide.html",
    "date": "2022-10-18",
    "keywords": [
        "demand",
        "hemlibra",
        "drug",
        "market",
        "quarter",
        "increase",
        "china",
        "burger",
        "revenue",
        "company",
        "schwan",
        "percentage",
        "gantenerumab",
        "q3",
        "bln",
        "level",
        "covid",
        "slump",
        "testing",
        "treatment",
        "sclerosis",
        "thirdquarter",
        "statement",
        "incidence",
        "rate",
        "covid19",
        "executive",
        "severin",
        "call",
        "bestseller",
        "ocrevus",
        "effect",
        "currency",
        "brokerage",
        "cancer",
        "immunotherapy",
        "tecentriq",
        "guidance",
        "lowsingle",
        "digit",
        "exchange",
        "gain",
        "share",
        "range",
        "ceo",
        "roche",
        "trial",
        "end",
        "month",
        "protein",
        "type",
        "miranda",
        "murray",
        "donovan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}